MRK  Merck & Company Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

165.2B

Vuru Grade

47.84/100

Current Price

$57.26
+0.63 (+1.11%)

Growth Price

$46.96
Overvalued by 17.99%

Stability Price

$23.37
Overvalued by 59.19%

Company Metrics

  • 29.84 P/E
  • 3.75 P/S
  • 3.4 P/B
  • 1.898 EPS
  • 10.80% Cash ROIC
  • 0.98 Cash Ratio
  • 1.76 / 3.11% Dividend
  • 9.59M Avg. Vol.
  • 2.89B Shares
  • 165.2B Market Cap.

Company Description

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company's Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, ...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

A Quick Look at Merck & Co. Inc.'s Drug Development Pipeline
Motley Fool - Oct 13, 2014
Today, I'd suggest we take a closer look at Merck's (NYSE: MRK ) drug development pipeline in order to get a better idea of how well the company is preparing for its future beyond patent expirations, as well as note which handful of developing drugs ...
Bayer closes acquisition of consumer care business of Merck & Co., Inc. for ...
MarketWatch - Oct 1, 2014
Bayer has completed the global acquisition of the consumer care business of the U.S. pharmaceuticals group Merck & Co., Inc., Whitehouse Station, New Jersey. The transaction closed on October 1, 2014, following receipt of required antitrust approvals.
Company Update: Merck & Co Inc (NYSE:MRK) - Merck Completes Sale of ... - Jutia Group
Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.?
DailyFinance - Oct 4, 2014
Dividend stocks are arguably the most critical component to the success of any long-term investor. According to the latest statistics from FactSet, S&P 500 companies paid out a whopping $91.5 billion in dividends during the second quarter, or an ...
Ragwitek by Merck & Co, Inc, and Catalent Pharma
Pharmacy Times - Oct 7, 2014
The FDA has approved sublingual Ragwitek (Short Ragweed Pollen Allergen Extract) tablets as an immunotherapy option for selected patients with confirmed ragweed pollen–induced allergic rhinitis.
Ex-Merck analyst faces insider trading charges on merger tips
Reuters - Oct 14, 2014
NEW YORK Oct 14 (Reuters) - Federal prosecutors in New York charged a former Merck & Co Inc employee with conspiracy to commit fraud for tipping a contact about potential mergers, including Merck's takeover of Idenix Pharmaceuticals ahead of a public ...
Company Update (NYSE:MRK): Ex-Merck analyst faces insider trading charges ... - Jutia Group
Quick Fact With News Roundup- Merck & Co., Inc. (NYSE:MRK), Sanofi SA (ADR ...
StreetWise Report - 15 hours ago
Merck & Co., Inc. (NYSE:MRK) and actress S. Epatha Merkerson are carrying the America's Diabetes Challenge: Get to Your Goals program to Atlanta, Georgia to inspire African Americans with type II diabetes to identify their A1C their regular blood sugar ...
Morning Watch List : Merck & Co. Inc. (NYSE:MRK), Cisco Systems, Inc ... - Street Newswire (registration)
Merck & Co. (MRK) Scheduled to Post Earnings on Monday - WKRB News
Merck Still Looks Very Expensive (MRK)
Seeking Alpha (registration) - Oct 14, 2014
In the case of Merck (NYSE:MRK), earnings growth deteriorated from the second quarter of 2012 and it has been flat lining, so to speak, since then.
Hot News : Merck & Co. Inc. (NYSE:MRK), Alcoa Inc. (NYSE:AA), Sprint ...
Street Newswire (registration) - Oct 22, 2014
Swiss drug manufacturer Roche and U.S. group Merck & Co., Inc. (NYSE:MRK) are going to present data on their competingimmune-therapy medicines in breast cancer in December, spreading the novel tactic to fighting tumor's to another cancer type.
Merck & Co. (MRK) Set to Announce Earnings on Monday - sleekmoney
Stock Runners : AbbVie Inc. (NYSE:ABBV), International Business Machines ... - WallStreet Scope
Merck & Co., Inc. Stock Still Holding Its Position As A Big-Pharma Leader
Benzinga - Sep 29, 2014
Merck & Co. (NYSE: MRK) is the perfect example of a go-to “safe harbor” stock when market conditions turn bearish, as they did last Thursday and early Monday morning.
Company Update: Merck & Co Inc (NYSE:MRK) - Merck Announces Proposed ...
Jutia Group - Oct 6, 2014
Merck & Co Inc (NYSE:MRK) [Business Wire] - Merck & Co., Inc. , known as MSD outside the United States and Canada, announced today the commencement of a public offering of three series of Euro denominated senior unsecured notes due 2021, 2026 ...
Merck Announces Proposed Public Debt Offering - Business Wire (press release)
Merck Prices EUR 2.5 Bln Debt Offering - RTT News